StockData

Goldenwell Biotech, Inc. (GWLL) stock

GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)

Close on Oct 19, 2026Market cap $64.35MP/E –Yield –

Goldenwell Biotech profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Goldenwell Biotech's profit margin for the twelve months ending Jun 30, 2026 was -512940.0%. For fiscal 2025 it was -539038.2%, against -94602.9% the year before. The highest annual figure on record is -732.6% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-539038.2%−444435.3
FY2024Dec 31, 2024-94602.9%−88210.7
FY2023Dec 31, 2023-6392.2%−4331.3
FY2022Dec 31, 2022-2060.9%−1328.2
FY2021Dec 31, 2021-732.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q4 FY2025Dec 31, 2025-363163.6%−353350.6
Q2 FY2024Jun 30, 2024-35913.7%−33550.4
Q4 FY2023Dec 31, 2023-7999.6%−7989.1
Q3 FY2023Sep 30, 2023-9268.6%−8546.8
Q2 FY2023Jun 30, 2023-9813.0%−1405.0
Q1 FY2023Mar 31, 2023-2363.3%−1761.3
Q3 FY2022Sep 30, 2022-10.5%+135.5
Q2 FY2022Jun 30, 2022-721.8%+1410.6
Q1 FY2022Mar 31, 2022-8408.1%–
Q4 FY2021Dec 31, 2021-602.0%–
Q3 FY2021Sep 30, 2021-145.9%–
Q2 FY2021Jun 30, 2021-2132.4%–

More Goldenwell Biotech figures

See a number that looks wrong?